经颅直流电刺激
癫痫
麻醉
医学
随机对照试验
耐火材料(行星科学)
心理学
听力学
刺激
外科
内科学
精神科
天体生物学
物理
作者
Dongju Yang,Rui Ma,Nuo Yang,Ke Sun,Jiaqi Han,Yiran Duan,Aihua Liu,Xuan Zhao,Ting Li,Jing Liu,Wenjing Liu,Fang Chen,Ning Hu,Cuiping Xu,Chunqiu Fan,Yuping Wang
标识
DOI:10.1016/j.yebeh.2022.108876
摘要
Abstract
Objective
Although clinical trials have demonstrated that cathodal transcranial direct current stimulation (tDCS) is effective for seizure reduction, its long-term efficacy is unknown. This study aimed to determine the long-term effects of repeated cathodal long tDCS sessions on seizure suppression in patients with refractory epilepsy. Methods
Patients were recruited to participate in an extended phase of a previous randomized, double-blind, sham-controlled, three-arm, parallel, multicenter study on tDCS. The patients were divided into an active tDCS group (20 min of tDCS per day) and an intensified tDCS group (2 × 20 min of tDCS per day). Each tDCS session lasted 2 weeks and the patients underwent repeated sessions at intervals of 2 to 6 months. The cathode was placed over the epileptogenic focus with the current intensity set as 2 mA. Seizure frequency reduction from baseline was analyzed using the Wilcoxon signed-rank test for two related samples. A generalized estimating equation model was used to estimate group, time, and interaction effects. Results
Among the 19 patients who participated in the extended phase, 11 were in the active tDCS group and underwent 2–16 active tDCS sessions, and eight were in the intensified tDCS group and underwent 3–11 intensified tDCS sessions. Seizure reduction was significant from the first to the seventh follow-up, with a median seizure frequency reduction of 41.7%–83.3% (p < 0.05). Compared to the regular tDCS protocol, each intensified tDCS session substantially decreased seizure frequency by 0.3680 (p < 0.05). One patient experienced an increase of 8.5%–232.8% in the total number of seizures during three treatment sessions and follow-ups. Conclusion
Repeated long cathodal tDCS sessions yielded significant and progressive long-term seizure reductions in patients with refractory focal epilepsy.
科研通智能强力驱动
Strongly Powered by AbleSci AI